ZBTB6

gene
On this page

Also known as ZID

Summary

ZBTB6 (zinc finger and BTB domain containing 6, HGNC:16764) is a protein-coding gene on chromosome 9q33.2, encoding Zinc finger and BTB domain-containing protein 6 (Q15916). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II; regulation of cytokine production; and regulation of immune system process. Located in mitochondrion and nucleoplasm.

Source: NCBI Gene 10773 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 35 total
  • MANE Select transcript: NM_006626

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:16764
Approved symbolZBTB6
Namezinc finger and BTB domain containing 6
Location9q33.2
Locus typegene with protein product
StatusApproved
AliasesZID
Ensembl geneENSG00000186130
Ensembl biotypeprotein_coding
OMIM605976
Entrez10773

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 4 protein_coding

ENST00000373659, ENST00000899189, ENST00000899190, ENST00000915652

RefSeq mRNA: 1 — MANE Select: NM_006626 NM_006626

CCDS: CCDS6846

Canonical transcript exons

ENST00000373659 — 2 exons

ExonStartEnd
ENSE00001377956122913251122913323
ENSE00001461163122908056122912081

Expression profiles

Bgee: expression breadth ubiquitous, 182 present calls, max score 88.34.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.0690 / max 227.7270, expressed in 1715 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
10239912.06901715

Top tissues by expression

282 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cortical plateUBERON:000534388.34gold quality
calcaneal tendonUBERON:000370186.66gold quality
ganglionic eminenceUBERON:000402381.59gold quality
islet of LangerhansUBERON:000000680.66gold quality
ventricular zoneUBERON:000305378.27gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047377.75silver quality
stromal cell of endometriumCL:000225577.72gold quality
adrenal tissueUBERON:001830377.57gold quality
muscle of legUBERON:000138376.63gold quality
gastrocnemiusUBERON:000138876.23gold quality
rectumUBERON:000105276.07gold quality
hindlimb stylopod muscleUBERON:000425275.42gold quality
granulocyteCL:000009475.03gold quality
lymph nodeUBERON:000002975.03gold quality
leukocyteCL:000073874.76gold quality
monocyteCL:000057674.56gold quality
descending thoracic aortaUBERON:000234574.16gold quality
mononuclear cellCL:000084274.11gold quality
gall bladderUBERON:000211073.93gold quality
pancreasUBERON:000126473.43gold quality
olfactory segment of nasal mucosaUBERON:000538673.35gold quality
right adrenal gland cortexUBERON:003582773.23gold quality
smooth muscle tissueUBERON:000113573.04gold quality
vermiform appendixUBERON:000115472.95gold quality
right adrenal glandUBERON:000123372.62gold quality
left adrenal glandUBERON:000123472.60gold quality
lower esophagus mucosaUBERON:003583472.25gold quality
prefrontal cortexUBERON:000045172.21gold quality
body of pancreasUBERON:000115072.20gold quality
small intestine Peyer’s patchUBERON:000345472.03gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-MTAB-6058no134.36
E-ANND-3no2.30

Regulation

Is transcription factor: yes

JASPAR motifs

MotifNameFamily
MA1581.1ZBTB6More than 3 adjacent zinc fingers
MA1581.2ZBTB6More than 3 adjacent zinc fingers

JASPAR matrix evidence (PMIDs): PMID:16381825

miRNA regulators (miRDB)

178 targeting ZBTB6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5692A100.0074.406850
HSA-MIR-3646100.0073.565283
HSA-MIR-5692B100.0071.322622
HSA-MIR-5692C100.0071.322622
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-188-3P100.0068.761240
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-3163100.0077.238605
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-6758-5P100.0066.211470
HSA-MIR-126-5P100.0072.713180
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-656-3P100.0072.152788
HSA-MIR-6856-5P100.0065.471298
HSA-MIR-3924100.0072.092394
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-366299.9973.825684
HSA-MIR-428299.9975.366408
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-548N99.9871.944170
HSA-MIR-1213699.9872.815713
HSA-MIR-548P99.9872.253784
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-60799.9773.625593
HSA-MIR-548AN99.9770.912817

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusZbtb6ENSMUSG00000066798
rattus_norvegicusZbtb6ENSRNOG00000009340

Paralogs (28): ZNF280C (ENSG00000056277), ZBTB25 (ENSG00000089775), PRDM13 (ENSG00000112238), BCL6 (ENSG00000113916), FEZF1 (ENSG00000128610), ZBTB46 (ENSG00000130584), PRDM12 (ENSG00000130711), ZNF280D (ENSG00000137871), NACC2 (ENSG00000148411), FEZF2 (ENSG00000153266), ZBTB7B (ENSG00000160685), NACC1 (ENSG00000160877), BCL6B (ENSG00000161940), GFI1 (ENSG00000162676), GFI1B (ENSG00000165702), ZBTB49 (ENSG00000168826), ZNF280A (ENSG00000169548), ZNF581 (ENSG00000171425), ZNF524 (ENSG00000171443), ZBTB26 (ENSG00000171448), ZBTB21 (ENSG00000173276), ZNF683 (ENSG00000176083), ZBTB33 (ENSG00000177485), ZBTB3 (ENSG00000185670), ZBTB14 (ENSG00000198081), ZBTB12 (ENSG00000204366), ZNF580 (ENSG00000213015), ZNF280B (ENSG00000275004)

Protein

Protein identifiers

Zinc finger and BTB domain-containing protein 6Q15916 (reviewed: Q15916)

Alternative names: Zinc finger protein 482, Zinc finger protein with interaction domain

All UniProt accessions (1): Q15916

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Tissue specificity. Widely expressed with highest levels in brain.

RefSeq proteins (1): NP_006617* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000210BTB/POZ_domDomain
IPR011333SKP1/BTB/POZ_sfHomologous_superfamily
IPR013087Znf_C2H2_typeDomain
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050457ZnFinger_BTB_dom_containFamily

Pfam: PF00096, PF00651

UniProt features (9 total): zinc finger region 4, chain 1, domain 1, region of interest 1, compositionally biased region 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q15916-F159.180.10

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 202

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 123 (showing top): TTTGTAG_MIR520D, BROWNE_HCMV_INFECTION_16HR_UP, GTGCCTT_MIR506, MODULE_285, GOBP_CYTOKINE_PRODUCTION, ACATTCC_MIR1_MIR206, DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP, CTTTGTA_MIR524, AACATTC_MIR4093P, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, GEORGES_TARGETS_OF_MIR192_AND_MIR215, GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MARTENS_TRETINOIN_RESPONSE_DN, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II

GO Biological Process (3): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of cytokine production (GO:0001817), regulation of immune system process (GO:0002682)

GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), DNA binding (GO:0003677), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (3): nucleus (GO:0005634), nucleoplasm (GO:0005654), mitochondrion (GO:0005739)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
intracellular membrane-bounded organelle2
regulation of transcription by RNA polymerase II1
transcription by RNA polymerase II1
negative regulation of DNA-templated transcription1
cytokine production1
regulation of gene expression1
regulation of multicellular organismal process1
immune system process1
regulation of biological process1
cis-regulatory region sequence-specific DNA binding1
negative regulation of transcription by RNA polymerase II1
DNA-binding transcription factor activity, RNA polymerase II-specific1
DNA-binding transcription repressor activity1
nucleic acid binding1
transition metal ion binding1
binding1
cation binding1
nuclear lumen1
cellular anatomical structure1
cytoplasm1

Protein interactions and networks

STRING

686 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZBTB6ACTA1P02568762
ZBTB6ANP32EQ9BTT0509
ZBTB6KLHL18O94889403
ZBTB6HDAC2Q92769388
ZBTB6ZSCAN1Q8NBB4377
ZBTB6KCTD2Q14681351
ZBTB6BTBD7Q9P203347
ZBTB6TMEM106AQ96A25334
ZBTB6C11orf71Q6IPW1324
ZBTB6FAM110BQ8TC76324
ZBTB6UBAC1Q9BSL1318
ZBTB6TRMT2BQ96GJ1292
ZBTB6FERRY3Q9NQ89290
ZBTB6ANKFY1Q9P2R3288
ZBTB6L3MBTL3Q96JM7278

IntAct

40 interactions, top by confidence:

ABTypeScore
ZBTB6ZBTB26psi-mi:“MI:0915”(physical association)0.720
SUMO1P1ZBTB6psi-mi:“MI:0915”(physical association)0.560
ZBTB6SUMO1psi-mi:“MI:0915”(physical association)0.560
ZBTB6SUMO1P1psi-mi:“MI:0915”(physical association)0.560
SUMO1ZBTB6psi-mi:“MI:0915”(physical association)0.560
ZBTB6PLEKHF2psi-mi:“MI:0915”(physical association)0.560
ZNF250ZBTB6psi-mi:“MI:0915”(physical association)0.560
ZBTB6FAM9Apsi-mi:“MI:0915”(physical association)0.560
ZBTB48ZBTB6psi-mi:“MI:0915”(physical association)0.560
RNF4ZBTB6psi-mi:“MI:0915”(physical association)0.560
PRKNZBTB6psi-mi:“MI:0915”(physical association)0.560
VHLZBTB6psi-mi:“MI:0915”(physical association)0.560
ZBTB6ZBTB6psi-mi:“MI:0915”(physical association)0.370
SKILZBTB6psi-mi:“MI:0915”(physical association)0.370
ATF7IPZBTB6psi-mi:“MI:0915”(physical association)0.370
ZBTB6ZBTB26psi-mi:“MI:0915”(physical association)0.000
PLEKHF2ZBTB6psi-mi:“MI:0915”(physical association)0.000
ZNF250ZBTB6psi-mi:“MI:0915”(physical association)0.000
ZBTB6FAM9Apsi-mi:“MI:0915”(physical association)0.000

BioGRID (15): ZBTB6 (Two-hybrid), ZBTB26 (Two-hybrid), SUMO1P1 (Two-hybrid), SAR1B (Affinity Capture-MS), ZBTB6 (Two-hybrid), ZBTB6 (Two-hybrid), ZBTB6 (Two-hybrid), ZBTB6 (Two-hybrid), ZNF250 (Two-hybrid), ZBTB48 (Two-hybrid), ZBTB6 (Two-hybrid), ZBTB6 (Two-hybrid), ZBTB6 (Two-hybrid), ZBTB6 (Affinity Capture-Western), ZBTB6 (Two-hybrid)

ESM2 similar proteins: A0JN76, A1L2U9, B1WAZ8, B1WBU4, O15060, O35260, O43298, O93567, P14404, P41182, P41183, Q05516, Q0IH98, Q0IJ29, Q0P4X6, Q0V8G8, Q0VCJ6, Q15916, Q1L8W0, Q3B725, Q3SWU4, Q5TC79, Q5ZM39, Q6NRM8, Q6P882, Q6YND2, Q7TQG0, Q7TSZ8, Q7ZWZ4, Q801P1, Q80X44, Q86UZ6, Q8BID6, Q8CII0, Q8K088, Q8K0L9, Q8N680, Q8NAP8, Q8NCN2, Q8NCP5

Diamond homologs: A0JMG1, A1YPR0, B0WWP2, B1WBS3, B2RXF5, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, D3Z8N4, E0CZ16, E1B932, E7F6F9, E9Q4F2, F1LZ52, F1LZF0, F1MBP6, O14682, O15060, O35709, O43791, O88939, O93567, O94889, O95198, O95365, P0DMR5, P34568, P41182, P41183, Q04652, Q08DK3, Q0D2A9, Q0IHH9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

35 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance32
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

194 predictions. Top by Δscore:

VariantEffectΔscore
9:122912078:CAAT:Cacceptor_gain0.9900
9:122913250:CCGA:Cdonor_gain0.9900
9:122913244:CACT:Cdonor_loss0.9800
9:122913245:A:ACdonor_gain0.9800
9:122913246:C:CCdonor_gain0.9800
9:122913247:T:TAdonor_loss0.9800
9:122913248:C:CCdonor_loss0.9800
9:122913249:A:ACdonor_gain0.9800
9:122913250:C:CCdonor_gain0.9800
9:122913246:CTCA:Cdonor_gain0.9700
9:122913245:AC:Adonor_loss0.9500
9:122913246:CT:Cdonor_gain0.9400
9:122912082:C:CCacceptor_gain0.9300
9:122912079:AATCT:Aacceptor_loss0.9200
9:122912080:ATCT:Aacceptor_loss0.9200
9:122912081:TCTA:Tacceptor_loss0.9200
9:122912082:C:CGacceptor_loss0.9200
9:122912083:T:Aacceptor_loss0.9200
9:122913248:CACCG:Cdonor_gain0.9100
9:122913249:ACCGA:Adonor_gain0.9100
9:122913250:CCGAC:Cdonor_gain0.9100
9:122912929:TC:Tdonor_gain0.9000
9:122912930:CC:Cdonor_gain0.9000
9:122912936:C:Adonor_gain0.9000
9:122912097:C:CTacceptor_loss0.8900
9:122911435:TTAAA:Tdonor_gain0.8700
9:122913243:TCAC:Tdonor_loss0.8700
9:122912935:T:TAdonor_gain0.8600
9:122913250:CCG:Cdonor_gain0.8600
9:122912084:A:Cacceptor_loss0.8400

AlphaMissense

2833 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
9:122910875:G:CH400D1.000
9:122910883:A:GL397P1.000
9:122910900:G:CF391L1.000
9:122910900:G:TF391L1.000
9:122910901:A:GF391S1.000
9:122910902:A:GF391L1.000
9:122910923:A:GC384R1.000
9:122910945:G:CH376Q1.000
9:122910945:G:TH376Q1.000
9:122910957:G:CH372Q1.000
9:122910957:G:TH372Q1.000
9:122910959:G:CH372D1.000
9:122910959:G:TH372N1.000
9:122910967:A:GL369P1.000
9:122910984:A:CF363L1.000
9:122910984:A:TF363L1.000
9:122910985:A:GF363S1.000
9:122910986:A:GF363L1.000
9:122910996:G:CC359W1.000
9:122910998:A:GC359R1.000
9:122911005:A:CC356W1.000
9:122911007:A:GC356R1.000
9:122911011:A:CF354L1.000
9:122911011:A:TF354L1.000
9:122911013:A:GF354L1.000
9:122911041:G:CH344Q1.000
9:122911041:G:TH344Q1.000
9:122911043:G:CH344D1.000
9:122911045:C:GR343P1.000
9:122911051:A:GL341P1.000

dbSNP variants (sampled 300 via entrez): RS1000074128 (9:122908471 A>C,G), RS1000862254 (9:122914531 GTAA>G), RS1002385562 (9:122910118 G>A), RS1002414909 (9:122909853 A>G), RS1002810229 (9:122909670 A>G), RS1003057670 (9:122913490 G>C), RS1003088887 (9:122913299 C>G), RS1003390406 (9:122912143 A>C,G), RS1003756288 (9:122911808 A>G), RS1004023820 (9:122915260 T>C,G), RS1004257620 (9:122915019 T>TC), RS1004435384 (9:122908541 A>G), RS1004714336 (9:122914814 CTCAG>C), RS1004940010 (9:122908344 T>C), RS1005971152 (9:122909535 A>G)

Disease associations

OMIM: gene MIM:605976 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST005951_64Body mass index2.000000e-10
GCST010703_296Brain morphology (MOSTest)2.000000e-14

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004340body mass index
EFO:0004346neuroimaging measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

34 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Aciddecreases expression3
sodium arsenitedecreases expression, increases abundance, increases expression2
Air Pollutantsaffects expression, increases abundance, decreases expression2
Phenylmercuric Acetateaffects cotreatment, decreases expression2
Tobacco Smoke Pollutionincreases expression2
aristolochic acid Idecreases expression1
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
TAK-243increases sumoylation1
TL8-506affects cotreatment, increases expression1
dicrotophosdecreases expression1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
trichostatin Adecreases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608affects binding, increases reaction1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
dorsomorphinaffects cotreatment, decreases expression1
jinfukangdecreases expression1
Leflunomideincreases expression1
Arsenicincreases abundance, increases expression1
Cadmiumincreases abundance, increases expression1
Caffeinedecreases phosphorylation1
Doxorubicindecreases expression1
Endosulfandecreases expression1
Formaldehydedecreases expression1
Ozoneaffects expression, increases abundance1
Silicon Dioxideincreases expression1
Urethaneincreases expression1
Cyclosporinedecreases expression1
Aflatoxin M1decreases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_XV93HEK293 eGFP-ZBTB6Transformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.